Literature DB >> 17141366

Verrucous carcinoma of the scalp.

Sean F Pattee1, Jeremy Bordeaux, Meera Mahalingam, Yuval B Nitzan, Mary E Maloney.   

Abstract

Verrucous carcinoma is a distinctive form of low-grade squamous cell carcinoma. It typically involves the oral cavity, larynx, esophagus, and skin. Cutaneous lesions typically arise in the genitocrural area and plantar surface of the foot, with rare case reports of verrucous carcinoma arising elsewhere on the body. Human papillomaviruses, predominately types 6 and 11, have been associated with some case reports. We present a case of verrucous carcinoma arising on the scalp with negative human papillomavirus testing in a relatively young patient.

Entities:  

Mesh:

Year:  2006        PMID: 17141366     DOI: 10.1016/j.jaad.2006.08.059

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Angiogenesis, Proliferative Activity and DNA Ploidy in Oral Verrucous Carcinoma: A Comparative Study Including Verrucous Hyperplasia and Squamous Cell Carcinoma.

Authors:  Saumyaranjan Mallick; Monika Breta; Siddhartha Datta Gupta; Amit Kumar Dinda; Biddhu K Mohanty; Manoj K Singh
Journal:  Pathol Oncol Res       Date:  2015-07-09       Impact factor: 3.201

Review 2.  Temporal bone verrucous carcinoma: outcomes and treatment controversy.

Authors:  Mia E Miller; Neil Martin; Guy F Juillard; Sunita Bhuta; Akira Ishiyama
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-26       Impact factor: 2.503

3.  Multiple synchronous verrucous carcinomas of the scalp in the background of generalized verruca vulgaris.

Authors:  Arvind Krishnamurthy; Vijayalakshmi Ramshankar; Thangaraj Viveka Soundara; Urmila Majhi
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

4.  An individual drug-therapy and genetic testing report of temporal bone verrucous carcinoma.

Authors:  Haolei Tan; Yong Liu; Gangcai Zhu; Leiming Pi; Donghai Huang; Xin Zhang
Journal:  Onco Targets Ther       Date:  2014-09-04       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.